83 related articles for article (PubMed ID: 8973777)
1. How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study.
Hansson L
Blood Press Suppl; 1996; 4():16-9. PubMed ID: 8973777
[TBL] [Abstract][Full Text] [Related]
2. The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study.
Hansson L; Zanchetti A
Blood Press; 1995 May; 4(3):133-6. PubMed ID: 7670645
[TBL] [Abstract][Full Text] [Related]
3. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group.
Borhani NO; Brugger SB; Byington RP
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S23-9. PubMed ID: 1695298
[TBL] [Abstract][Full Text] [Related]
5. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
Zannad F
Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
[TBL] [Abstract][Full Text] [Related]
6. Interventional clinical trials using noninvasive ultrasound end points: the Multicenter Isradipine/Diuretic Atherosclerosis Study. The MIDAS Research Group.
Bond MG; Strickland HL; Wilmoth SK; Safrit A; Phillips R; Szostak L
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S30-3. PubMed ID: 1695299
[TBL] [Abstract][Full Text] [Related]
7. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
Borhani NO
Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).
Zanchetti A
Blood Press Suppl; 1996; 4():30-5. PubMed ID: 8973780
[TBL] [Abstract][Full Text] [Related]
9. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.
Applegate WB; Byington RP
Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
[TBL] [Abstract][Full Text] [Related]
11. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
Hoogerbrugge N; de Groot E; de Heide LH; de Ridder MA; Birkenhägeri JC; Stijnen T; Jansen H
Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707
[TBL] [Abstract][Full Text] [Related]
12. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479
[TBL] [Abstract][Full Text] [Related]
13. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
Grimm RH; Flack JM; Byington R; Bond G; Brugger S
Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640
[TBL] [Abstract][Full Text] [Related]
14. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
Furberg CD; Byington RP; Borhani NA
Am J Med; 1989 Apr; 86(4A):37-9. PubMed ID: 2523653
[TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR
Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723
[TBL] [Abstract][Full Text] [Related]
16. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
Zanchetti A; Hennig M; Hollweck R; Bond G; Tang R; Cuspidi C; Parati G; Facchetti R; Mancia G
Circulation; 2009 Sep; 120(12):1084-90. PubMed ID: 19738145
[TBL] [Abstract][Full Text] [Related]
17. Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials.
Zanchetti A
Clin Exp Hypertens; 1996; 18(3-4):489-99. PubMed ID: 8743037
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical atherosclerosis evaluated by carotid artery intima-media thickness and the risk factors in children.
Yang XZ; Liu Y; Mi J; Tang CS; DU JB
Chin Med J (Engl); 2007 Mar; 120(5):359-62. PubMed ID: 17376303
[TBL] [Abstract][Full Text] [Related]
19. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
20. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
Bond MG; Mercuri M
J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S11-6. PubMed ID: 8852539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
